Who owns NEUROBO PHARMACEUTICALS INC?
- CUSIP Number: 64132r206
Tip: Access positions for across all investors
Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurobo Pharmaceuticals stock
Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Neurobo Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Neurobo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Sep 2023 | 70k | $33k |
| Citadel Advisors | Sep 2023 | 46k | $22k |
| Two Sigma Securities | Sep 2023 | 43k | $21k |
| Virtu Financial | Sep 2023 | 32k | $15k |
| Wells Fargo & Company | Sep 2023 | 188.00 | $88.999200 |
| UBS Group | Sep 2023 | 142.00 | $68.003800 |
| Bank of America Corporation | Sep 2023 | 8.00 | $4.000000 |